Home › Cardiotoxicity › California
Cardiotoxicity clinical trials in California
4 studies for Cardiotoxicity are looking for participants at sites in California.
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- City of Hope Comprehensive Cancer Center, Duarte
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Contra Costa Regional Medical Center, Martinez
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03418961The STOP-MED CTRCD Trial
- University of California, Los Angeles, Los Angeles
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT06183437AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Orange County Heart Institute, Orange
- Peerbridge Health, Pasadena
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
- Rady Children's Hospital, San Diego
RecruitingObservational study
Ages 13 to 39 · All sexes · Updated Jan 28, 2025 · NCT04262830From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.